MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS), a manufacturer of 3D printers and materials for personal use, prototyping and production, today announced it has observed an accelerated adoption of its Objet30 OrthoDesk 3D Printer, bringing the advantages of digital dentistry across the world to such diverse locations as Saudi Arabia, Australia, Mauritius Islands and Costa Rica.
Launched just this year, the Objet30 OrthoDesk 3D Printer is an affordable, simple-to-use desktop system which is designed to enable a cost-effective entry point to the many benefits of digital dentistry. This system opens up a new range of possibilities for smaller dental labs including the ability to significantly shorten delivery times, increase production capacity, and eliminate bulky model storage – which may contribute to the expansion of digital dentistry.
Prior to its introduction, due to cost considerations, 3D printers were only cost effective when utilized in larger labs. Leveraging Stratasys 3D printing technology, dental labs of any size can now efficiently produce stone models, orthodontic appliances, delivery and positioning trays, retainers and surgical guides.
“The Objet30 OrthoDesk 3D Printer is contributing to shortening lab service delivery times for our customers in Brazil; I definitely see it as a game-changer,” explained Dr. Bruno Gribel, CEO of Compass3D Brazil.
“We are witnessing a growing demand for our new Objet30 OrthoDesk 3D Printer,” said Avi Cohen, Director, Global Dental, Stratasys. “As dental labs constantly explore new ways to grow their business and increase productivity, they are looking to Stratasys’ growing portfolio of customized 3D printers and unique dental materials. These solution offerings provide highly accurate and flexible 3D printing technology to smaller labs and clinics who want to benefit from the future of dentistry, today.”
Lab owners on Stratasys 3D Printing:
“With industry-leading precision, the Objet30 OrthoDesk enables labs to
create accurate, smooth, orthodontic models more easily than ever
Michael Wright, Laboratory Manager at Orthodent Laboratory Inc.
“With the Objet30 OrthoDesk, orthodontists can now automate the entire
workflow from CAD file to model fabrication, significantly accelerating
production times and increasing capacity.”
Kendall Lamp, CEO of Accutech Laboratory
“The Objet30 OrthoDesk comes with innovative dental printing materials.
Stone models, orthodontic appliances, delivery and positioning trays,
retainers and surgical guides can all be produced significantly faster
and much more accurately than before.”
Mike Lomax, President of Reliable Arts Dental Lab, Costa Rica
The Stratasys Objet-line of Dental 3D printers has received various awards in recent years, including the Dental Advisor 2013 Top Innovative Equipment Award, and the Dental Labs Products 2011 Readers Choice Award.
For more information and to see digital dentistry in action visit www.StratasysDental.com
Stratasys Ltd. (Nasdaq: SSYS), headquartered in Minneapolis, Minn. and Rehovot, Israel, manufactures 3D printers and materials for prototyping and production. The company’s patented FDM® and PolyJetTM 3D printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape, and the company operates the RedEye digital-manufacturing service. Stratasys has more than 1700 employees, holds over 500 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership. Online at: www.stratasys.com or http://blog.stratasys.com
Stratasys, FDM, and RedEye are registered trademarks, and PolyJet and OrthoDesk are trademarks of Stratasys Ltd. and or its subsidiaries or affiliates.
Cautionary Statement Regarding Forward-Looking Statements
Certain information included or incorporated by reference in this press may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified. These forward-looking statements may include, but are not limited to, statements relating to the company’s objectives, plans and strategies, statements regarding the company’s products and their expected performance, statements that contain projections of results of operations or of financial condition (including, with respect to the MakerBot merger) and all statements (other than statements of historical facts) that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. The company has based these forward-looking statements on assumptions and assessments made by its management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things: the company’s ability to efficiently and successfully integrate the operations of Stratasys, Inc. and Objet Ltd. after their merger as well as the ability to successfully integrate MakerBot into Stratasys; the overall global economic environment; the impact of competition and new technologies; general market, political and economic conditions in the countries in which the company operates; projected capital expenditures and liquidity; changes in the company’s strategy; government regulations and approvals; changes in customers’ budgeting priorities; litigation and regulatory proceedings; and those factors referred to under “Risk Factors”, “Information on the Company”, “Operating and Financial Review and Prospects”, and generally in the company’s annual report on Form 20-F for the year ended December 31, 2012 filed with the U.S. Securities and Exchange Commission and in other reports that the Company has filed with the SEC. Readers are urged to carefully review and consider the various disclosures made in the company’s SEC reports, which are designed to advise interested parties of the risks and factors that may affect its business, financial condition, results of operations and prospects. Any forward-looking statements in this press release are made as of the date hereof, and the company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Attention Editors, if you publish reader-contact information, please use:
- USA 1-877-489-9449
- Europe/Middle East/Africa +49-7229-7772-0
- Asia Pacific +852 39448888